6,7-dibromo-1H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one, 97%, 250mg

(2,2-Dimethyl-1,3-dioxan-5-yl)methanol, 98.0%, 10g

1,3-BIS(DICYCLOHEXYLPHOSPHINO)PROPANE, 90%, 1g

Tétrahydrofurane, min 99,5 %, pour la synthèse, 2,5 L, emballage en verre

Hexyl 2-Methylbutanoate>98.0%(GC)25g

3-allyl-6-methoxybenzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 500mg

4-sec-butoxy-3-methoxybenzaldehyde, 95.0%, 1g

(S)-1H-Indol-3-yl 2-(4-methylphenylsulfonamido)propanoate, 95.0%, 50mg

Olsalazine, 98%, 1g

5-Bromo-2-methyl-3-nitrobenzoic acid, 95.0%, 500g

N-methyl-N-[(3R)-piperidin-3-yl]acetamide hydrochloride, 95.0%, 500mg

2,6-Bis(trifluoromethyl)aniline, 95.0%, 5g

2-OXIRANECARBOXYLIC ACID, 2-[6-(4-CHLOROPHENOXY)HEXYL]-, ETHYL ESTER, (2R)-, 95%, 5mg